Go Pro

Progyny (PGNY) 10K Form and Latest SEC Filings 2026

Progyny logo
$26.00 0.00 (0.00%)
As of 08/28/2026 04:00 PM Eastern

Latest Progyny SEC Filings & Recent Activity

Progyny (NASDAQ:PGNY) has submitted 657+ documents to the U.S. Securities and Exchange Commission (SEC) since 2019. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Progyny's financial statements. The most recent filing was a Form 10-Q submitted on August 7, 2026.

Form 4
Progyny, Inc. Reports Ownership Change on Jul. 16, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-Q
Progyny Files Quarterly Report on Aug. 7, 2026

The 10-Q contains Progyny's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Progyny SEC Filing History

Browse Progyny's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
08/07/2026 8:00 AM
Progyny (1551306) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/16/2026 3:16 PM
Cummings Melissa B (2066495) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2026 8:46 AM
Cummings Melissa B (2066495) Reporting
Progyny (1551306) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2026 11:26 AM
KLEINER PERKINS CAUFIELD & BYERS XIII, LLC (1435899) Filed by
Progyny (1551306) Subject
Form SCHEDULE 13G/A
06/05/2026 3:38 PM
Anevski Peter (1576147) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 3:38 PM
Progyny (1551306) Issuer
Swartz Allison (1956339) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 3:38 PM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2026 12:39 PM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2026 10:19 AM
Progyny (1551306) Subject
Swartz Allison (1956339) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2026 3:52 PM
Clapp Geoffrey (2065409) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 8:59 AM
Progyny (1551306) Subject
Swartz Allison (1956339) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2026 2:03 PM
Clapp Geoffrey (2065409) Reporting
Progyny (1551306) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2026 11:22 AM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/01/2026 1:48 PM
Progyny (1551306) Subject
Scott Cheryl (1656979) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2026 3:16 PM
GORDON KEVIN K (1218483) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2026 9:17 AM
Progyny (1551306) Subject
Swartz Allison (1956339) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2026 10:25 AM
GORDON KEVIN K (1218483) Reporting
Progyny (1551306) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2026 8:13 AM
Progyny (1551306) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2026 3:20 PM
MORRIS DEBRA L (1838995) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 3:21 PM
Progyny (1551306) Issuer
Scott Cheryl (1656979) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 3:21 PM
Payson Norman (898544) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 3:22 PM
Park Jeffrey G (1406618) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 8:15 AM
Progyny (1551306) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2026 11:15 AM
Progyny (1551306) Subject
Scott Cheryl (1656979) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2026 2:07 PM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2026 10:52 AM
Cummings Melissa B (2066495) Reporting
Progyny (1551306) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2026 7:50 AM
Progyny (1551306) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2026 3:03 PM
Progyny (1551306) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2026 1:43 PM
Progyny (1551306) Subject
VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by
Form SCHEDULE 13G
04/16/2026 3:16 PM
Cummings Melissa B (2066495) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2026 7:33 AM
Progyny (1551306) Filer
Form DEF 14A
04/10/2026 7:34 AM
Progyny (1551306) Filer
Form DEFA14A
04/10/2026 7:34 AM
Progyny (1551306) Filer
Form ARS
03/31/2026 3:33 PM
Progyny (1551306) Filer
Form PRE 14A
03/27/2026 10:19 AM
Progyny (1551306) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/19/2026 4:12 PM
Clapp Geoffrey (2065409) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 3:15 PM
Progyny (1551306) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2026 3:35 PM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 3:36 PM
Progyny (1551306) Issuer
Swartz Allison (1956339) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2026 4:30 PM
Anevski Peter (1576147) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2026 4:31 PM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
My top 3 AI picks for the next decade (Ad)

Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel

Click here to get all three AI stock names from Alexander Green
03/04/2026 4:31 PM
Progyny (1551306) Issuer
Swartz Allison (1956339) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2026 4:32 PM
Cummings Melissa B (2066495) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2026 4:32 PM
Clapp Geoffrey (2065409) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2026 11:00 AM
Progyny (1551306) Subject
Swartz Allison (1956339) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2026 1:59 PM
Progyny (1551306) Subject
Swartz Allison (1956339) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 1:54 PM
Progyny (1551306) Subject
Swartz Allison (1956339) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2026 8:25 AM
Progyny (1551306) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2026 8:18 AM
Progyny (1551306) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2026 3:05 PM
Progyny (1551306) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2026 7:12 AM
Progyny (1551306) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2026 5:00 PM
Progyny (1551306) Issuer
Schlanger David J (1576145) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 4:53 PM
Progyny (1551306) Issuer
Sturmer Michael E (1837043) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 4:58 PM
Anevski Peter (1576147) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2025 7:00 AM
Progyny (1551306) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2025 3:12 PM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 1:55 PM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/08/2025 3:23 PM
Progyny (1551306) Issuer
Swartz Allison (1956339) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 3:24 PM
Progyny (1551306) Issuer
Sturmer Michael E (1837043) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2025 3:26 PM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 8:41 AM
Progyny (1551306) Subject
Swartz Allison (1956339) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2025 9:24 AM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2025 8:39 AM
Progyny (1551306) Subject
Swartz Allison (1956339) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2025 4:03 PM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2025 3:48 PM
Payson Norman (898544) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2025 11:31 AM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2025 7:22 AM
Anevski Peter (1576147) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 6:47 PM
Anevski Peter (1576147) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 6:49 PM
Progyny (1551306) Issuer
Schlanger David J (1576145) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2025 8:06 AM
Progyny (1551306) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2025 3:14 PM
Progyny (1551306) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2025 10:44 AM
FMR LLC (315066) Filed by
Progyny (1551306) Subject
Form SCHEDULE 13G/A
10/02/2025 3:24 PM
Anevski Peter (1576147) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2025 3:26 PM
Progyny (1551306) Issuer
Schlanger David J (1576145) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2025 3:35 PM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2025 3:37 PM
Progyny (1551306) Issuer
Sturmer Michael E (1837043) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2025 3:39 PM
Progyny (1551306) Issuer
Swartz Allison (1956339) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 8:35 AM
Progyny (1551306) Subject
Swartz Allison (1956339) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2025 3:32 PM
Livingston Mark S. (1824161) Reporting
Progyny (1551306) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 3:40 PM
Progyny (1551306) Issuer
Sturmer Michael E (1837043) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 4:04 PM
Progyny (1551306) Issuer
Swartz Allison (1956339) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Progyny SEC Filings - Frequently Asked Questions

Progyny (PGNY) has submitted 657+ filings to the SEC since 2019. You can browse the complete history or filter by form type using the tools above.

Progyny's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Progyny's financial statements page.

The most recent filing was a Form 10-Q submitted on August 7, 2026. This was a quarterly financial update for 2025.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NASDAQ:PGNY are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 8/7/2026. New filings are added as they're published.
From Our Partners